# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Amit Dayal reiterates Aemetis (NASDAQ:AMTX) with a Buy and maintains $28 price target.
Aemetis (NASDAQ:AMTX) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.48) by ...
Truist Securities analyst Jordan Levy reiterates Aemetis (NASDAQ:AMTX) with a Hold and lowers the price target from $4 to $3.5.
Avian influenza continues to spread among animals and has infected four dairy workers in the US. Concerns about human-to-human ...
Truist Securities analyst Jordan Levy reiterates Aemetis (NASDAQ:AMTX) with a Hold and raises the price target from $3.5 to $4.
HC Wainwright & Co. analyst Amit Dayal reiterates Aemetis (NASDAQ:AMTX) with a Buy and maintains $28 price target.
Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity p...